Geen artikels gevonden...
01/06/2023
Nucleaire Geneeskunde
[18F]FDG Uptake and Expression of Immunohistochemical Markers Related to Glycolysis, Hypoxia, and Proliferation in Indeterminate Thyroid Nodules.
Mol Imaging Biol. 2023 Jun;25(3):483-494. doi: 10.1007/s11307-022-01776-4. Epub 2022 Oct 17. PMID: 36253663 Free PMC article. Clinical Trial. dr. Schelfhout Vanessa
01/06/2023
Nucleaire Geneeskunde
Direct co-registration of [18F]FDG uptake and histopathology in surgically excised malignancies of the head and neck: a feasibility study.
Eur J Nucl Med Mol Imaging. 2023 Jun;50(7):2127-2139. doi: 10.1007/s00259-023-06153-z. Epub 2023 Mar 1. PMID: 36854863 dr. Schelfhout Vanessa
01/10/2022
Nucleaire Geneeskunde
Impact of 18F-PSMA-11 PET/CT on Management of Biochemical Recurrence and High-Risk Prostate Cancer Staging : 18F-PSMA-11 PET/CT and Impact on Prostate Cancer Management.
Mol Imaging Biol. 2022 Oct;24(5):750-758. doi: 10.1007/s11307-022-01724-2. Epub 2022 Apr 11. PMID: 35411446 dr. Schelfhout Vanessa
01/11/2022
Nucleaire Geneeskunde
18F-PSMA-11 Versus 68Ga-PSMA-11 Positron Emission Tomography/Computed Tomography for Staging and Biochemical Recurrence of Prostate Cancer: A Prospective Double-blind Randomised Cross-over Trial.
Eur Urol. 2022 Nov;82(5):501-509. doi: 10.1016/j.eururo.2022.05.010. Epub 2022 Jun 8. PMID: 35690515 Clinical Trial. dr. Schelfhout Vanessa
04/11/2022
Nucleaire Geneeskunde
Impact of 18F-PSMA-11 PET/CT on Management of Biochemical Recurrence and High-Risk Prostate Cancer Staging : 18F-PSMA-11 PET/CT and Impact on Prostate Cancer Management
https://pubmed.ncbi.nlm.nih.gov/35411446/dr. Schelfhout Vanessa
06/12/2023
Nucleaire Geneeskunde
High-Resolution 18F-FDG PET/CT for Assessing Three-Dimensional Intraoperative Margins Status in Malignancies of the Head and Neck, a Proof-of-Concept.
PMID: 34442033 PMCID: PMC8397229 DOI: 10.3390/jcm10163737dr. Schelfhout Vanessa
06/12/2023
Nucleaire Geneeskunde
[18F]FDG Uptake and Expression of Immunohistochemical Markers Related to Glycolysis, Hypoxia, and Proliferation in Indeterminate Thyroid Nodules.
PMID: 36253663 PMCID: PMC10172288 DOI: 10.1007/s11307-022-01776-4dr. Schelfhout Vanessa
11/01/2022
Nucleaire Geneeskunde
18F-PSMA-11 Versus 68Ga-PSMA-11 Positron Emission Tomography/Computed Tomography for Staging and Biochemical Recurrence of Prostate Cancer: A Prospective Double-blind Randomised Cross-over Trial.
PMID: 35690515 DOI: 10.1016/j.eururo.2022.05.010dr. Schelfhout Vanessa
10/01/2022
Nucleaire Geneeskunde